Ezrin and inducible nitric oxide synthase in malignant proliferation of salivary gland pleomorphic adenoma

Chinese Journal of Cancer

Volumn 28, Issue 10, 2009, Pages

  Wang, You Yuan ^a   Chen, Wei Liang ^a   Zhang, Wei Xiong ^b   Bai, Zhi Bao ^c   Huang, Zhi Quan ^a   Li, Jin Song ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Department of Stomotology   (China)

^c The First People's Hospitalof Guangzhou ^*  (China)

Author keywords

Ezrin; Inducible nitric oxide synthase; Ki 67 nuclear antigen; Pleomorphic adenoma; Proliferation

Indexed keywords

EZRIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVARY GLAND PLEOMORPHIC ADENOMA;

EID: 79955763326     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.008.10793     Document Type: Article

References (21)

1. Schluter C, Duchrow M, Wohjemberg C, et al. The cell proliferation-associated antigen of Ki-67: a very large, ubiquitious nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins [J]. J Cell Biol, 1993, 123(3): 513-522.
2. Fais S, Demilito A, Lozupone F. The role of FAS to ezrin association in FAS-mediated apoptosis [J]. Apoptosis, 2005, 10(5): 941-947.
3. Hunter KW. Ezrin, a key component in tumor metastasis [J]. Trends Mol Med, 2004, 10(5): 201-204.
4. Weng WH, Ahlen J, Astrom K, et al. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas [J]. Clin Cancer Res, 2005, 11 (17): 6198-6204.
5. Chen WL, Yang L, Zeng SG, et al. Effect of using RNA interference to alter iNOS gene expression on the proliferation of tongue squamous cell carcinoma cell line Tca8113 [J]. Br J Oral Maxillofac Surg, 2008, 46(6): 435-438.
6. Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer [J]. J Natl Cancer Inst, 1998, 90(8): 587-596.
7. Li J. Advancement of medical imaging diagnosis in maxillofacial tumors [J]. Zhonghua Kou Qiang Yi Xue Za Zhi, 2006, 41 (8): 474-477. [in Chinese]
8. Chen Y, Tian KU, Geng, N, et al. Significance of matrix metalloproteinase and its tissue inhibitors in the biological behaviors of pleomorphic adenoma [J]. Zhonghua Kou Qiang Yi Xue Za Zhi, 2005, 40(1): 58-61. [in Chinese]
9. Mathew J, Hines JE, Obafunwa JO, et al. CD44 is expressed in hepatocellular carcinomas showing vascular invasion [J]. J Pathol, 1996, 179 (1): 74-79.
10. Katori H, Nozawa A, Tsukuda M. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma [J]. Auris Nasus Larynx, 2007, 34(1): 79-84.
11. Gary R, Bretscher A. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site [J]. Mol Biol Cell, 1995, 6(8): 1061-1075.
12. Hiscox S, Jiang WG. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/b-catenin [J]. J Cell Sci, 1999, 112(18): 3081-3090.
13. Krieg J, Hunter T. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin [J]. J Biol Chem, 1992, 267 (27): 19258-19265.
14. Takahashi K, Sasaki T, Mammoto A, et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/ moesin initiates the activation of the Rho small G protein [J]. J Biol Chem, 1997, 272(37): 23371-23375.
15. Moilanen J, Lassus H, Leminen A, et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients [J]. Gynecol Oncol, 2003, 90(2): 273-281.
16. Khanna C, Wan X, Bose S, et al. The membrane cytoskeleton linker ezrin is necessary for osteosarcoma metastasis [J]. Nat Med, 2004, 10(2): 182-186.
17. Wang YY, Chen WL, Yang ZH, et al. Ezrin expression in adenoid cystic carcinoma of salivary gland and its influence on metastasis, proliferation and invasion of the tumor[J]. Zhonghua Kou Qiang Yi Xue Za Zhi, 2009, 44 (4): 203-207. [in Chinese]
18. Chen WL, Li HG, Pan ZB, et al. Expression of nitric oxide synthase in squamous cell carcinoma of tongue and its correlation to prognosis [J]. Zhonghua Kou Qiang Yi Xue Za Zhi, 1998, 33(5): 152-154. [in Chinese]
19. Brennan PA, Umar T, Buckley J, et al. Expression of nitric oxide synthase in pleomorphic adenomas of the parotid [J]. Br J Oral Maxillofac Surg, 2000, 38(4): 338-342.
20. Zhang J, Peng B, Chen X. Expressions of nuclear factor kappa B, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome [J]. Clin Cancer Res, 2005, 11 (20): 7334-7343.
21. Glynne PA, Darling KE, Picot J, et al. Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output [J]. J Biol Chem, 2002, 277(36): 33132-33138.